Overview

Detailed Summary

Smruthi Organics Limited specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) focusing on anti-diabetic, anti-hypertension, and anti-infectives categories. They cater to a global clientele across Asia, Americas, and Africa.
The company operates two manufacturing facilities in Solapur, India, and has progressively expanded its product offerings since its incorporation in 1989.
In 2021-22, the Finished Dosage Formulations (FDF) division was fully operational, showcasing industrial advancement and scaling the company's capacity to deliver pharmaceutical products comprehensively.
Smruthi Organics has expanded its brand portfolio with the launch of 'ENERLIN' and 'SOLSITA', highlighting their commitment to innovation and market diversification.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 140 Cr
Volatility: Low Risk
P/E Ratio: 40.7
Industry P/E: 33.7
PEG Ratio: 7.5
P/B Ratio: 1.9
52W High: 164.00
52W Low: 95.00

Sales CAGR

1Y: -1.28%
3Y: -1.88%
5Y: -0.79%
10Y: 5.54%

Profit CAGR

1Y: -0.84%
3Y: -29.99%
5Y: -15.86%
10Y: 19.38%

ROE

TTM: 4.66%
3Y: 5.39%
5Y: 11.50%
10Y: 10.47%

ROCE

TTM: 7.75%
3Y: 8.14%
5Y: 15.95%
10Y: 16.60%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
ALPA		69.00	145 Cr	9.78	0.78	0.00	8.06	8.98	6.13
KREBSBIO		65.53	143 Cr	-8.45	0.00	0.00	10.40	-9.06	-10.37
SMRUTHIORG		119.45	137 Cr	39.86	1.86	0.00	4.66	7.75	3.31
LACTOSE		110.00	137 Cr	22.51	2.11	0.00	9.36	10.75	3.31
BALPHARMA		84.40	136 Cr	21.60	1.65	0.00	7.64	9.18	1.68
TYCHE		128.00	131 Cr	18.89	0.93	0.00	4.94	6.74	4.67
GODAVARI		123.75	125 Cr	30.64	1.78	0.00	5.39	5.94	2.04
Median: 7 Co.	—	110.00	137 Cr	21.60	1.65	0.00	7.64	7.75	3.31

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	23	40	27	29	31	38	19	32	22	29
Expenses	25	36	27	27	27	33	19	27	18	25
Operating Profit	-1.18	4.09	0.44	2.89	4.16	4.67	0.23	5.01	4.00	3.79
OPM %	-5.03	10.31	1.61	9.83	13.31	12.26	1.21	15.85	17.95	13.03
Other Income	0.00	0.06	0.00	0.01	0.00	0.08	0.09	0.01	-0.44	0.01
Interest	0.32	0.37	0.41	0.44	0.51	0.52	0.46	0.66	0.25	0.31
Depreciation	1.45	1.59	1.29	1.33	1.37	1.50	1.41	1.51	1.67	1.75
Profit Before Tax	-2.95	2.19	-1.25	1.13	2.29	2.73	-1.55	2.85	1.63	1.74
Tax %	22.37	30.59	26.40	31.86	35.37	18.32	29.68	27.72	14.11	38.51
Net Profit	-2.29	1.52	-0.92	0.78	1.48	2.23	-1.10	2.06	1.40	1.07
EPS in Rs	-2.00	1.33	-0.81	0.68	1.29	1.95	-0.96	1.80	1.22	0.93

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	85	98	137	131	127	133	141	128	126	118
Expenses	69	94	121	116	98	115	131	116	114	106
Operating Profit	16	3.86	17	15	29	18	9.78	12	12	12
OPM %	18.54	3.94	12.07	11.62	22.56	13.82	6.93	9.37	9.67	10.15
Other Income	0.98	0.21	0.88	4.42	0.56	0.58	0.11	0.08	0.09	NaN
Interest	4.37	4.09	3.58	3.18	1.09	0.98	0.82	1.41	1.87	1.93
Depreciation	3.97	4.07	4.14	4.39	3.95	4.26	4.57	5.65	5.50	5.61
Profit Before Tax	2.59	-4.68	9.76	12	24	14	4.49	4.97	4.90	4.60
Tax %	38.89	31.40	29.67	30.14	28.88	24.62	8.07	27.76	27.29	26.30
Net Profit	1.58	-3.21	6.86	8.45	17	10	4.13	3.59	3.56	3.39
EPS in Rs	4.75	-3.05	5.92	7.38	11.97	9.06	3.40	3.14	3.11	2.99
Dividend Payout %	0.00	0.00	11.12	13.55	20.07	33.08	51.68	47.77	48.23	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3.82	3.82	3.82	3.82	3.82	11	11	11	11	11
Reserves	27	28	25	33	39	49	56	57	58	60
Borrowings	31	27	29	28	16	9.90	2.82	5.70	12	17
Other Liabilities	41	26	27	37	30	21	18	32	37	23
Total Liabilities	103	85	85	101	88	92	88	106	118	112
Fixed Assets	32	30	30	30	32	31	33	37	40	45
CWIP	1.09	1.30	0.53	1.69	0.19	0.84	0.80	1.99	1.43	2.55
Investments	0.34	0.05	0.05	0.05	0.05	0.05	0.05	0.12	0.13	0.16
Other Assets	69	54	54	69	56	60	53	66	77	64
Total Assets	103	85	85	101	88	92	88	106	118	112

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	14	9.17	5.14	12	21	23	2.17	12	4.40	9.98
Cash from Investing Activity	0.16	-0.48	-3.21	-4.50	-4.52	-3.40	7.15	-10	-7.16	-11
Cash from Financing Activity	-14	-8.68	-1.77	-5.15	-17	-6.86	-12	-1.52	2.66	1.40
Net Cash Flow	-0.06	0.02	0.16	2.43	-0.58	13	-2.79	0.34	-0.11	-0.04

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	63.58%	63.58%	63.60%	63.84%	63.87%	63.87%	63.87%	64.73%	64.73%	64.73%	64.73%	64.73%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	36.42%	36.42%	36.40%	36.16%	36.13%	36.13%	36.13%	35.27%	35.27%	35.27%	35.27%	35.27%
Total Shareholders	5,107	5,605	5,752	5,877	5,869	5,972	5,959	5,905	6,047	6,356	6,181	6,035

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.